EP3246325 - Bibliographic data

CRISTAUX DE COMPOSÉ DE 2-ACYLAMINOTHIAZOLE

Last update 08/06/2025
Legal status Brevet délivré
Origin Européen

(73) Holder

ASTELLAS PHARMA INC.

3-11, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo 103-8411
Japon
(72) Inventors

Keizo SUGASAWA

c/o Astellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-ku
Tokyo 103-8411
Japon

Akio MIYAFUJI

c/o Astellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-ku
Tokyo 103-8411
Japon

Kenichi SUZUKI

c/o Astellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-ku
Tokyo 103-8411
Japon

Yuji AWAMURA

c/o Astellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome Chuo-ku
Tokyo 103-8411
Japon
(74) Agent

Mail recipient

OPILEX

32, Rue Victor Lagrange
69007
Lyon
France

(21) Request number EP17176670.2
(22) Request date 01/08/2012

(11) Publication number EP3246325
Publication date 25/03/2020

(54) Title of the invention CRISTAUX DE COMPOSÉ DE 2-ACYLAMINOTHIAZOLE
(51) International classification C07D 417/14A61K 31/496A61P 7/04
International classification (before reform) None

Claimed priority

(31) Number: 2011169730
(32) Date: 03/08/2011
(33) Country: JP

Initial application None
Divisional application None

Expected annuity Annuity: 14 - Amount: 365 € - Due date 01/09/2025
Last annuity Annuity: 13 - Payment date 23/08/2024

Publication None
History

Publication de la délivrance du brevet européen - Legal date 25/03/2020


Constitution de mandataire pour un dossier - Legal date 31/03/2020